Silence Therapeutics plc Stock OTC Markets
Stocks
SLNCF
GB00B9GTXM62
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
17:30:13 18/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 5.500 USD | -8.18% |
|
+20.22% | +175.00% |
| 08-18 | European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading | MT |
| 08-13 | European Equities Traded in the US Rise in Thursday Trading | MT |
| Market Cap | 627M 849M 733M 690M 1.18B 81.34B 1.2B 8.09B 3.17B 40.68B 3.19B 3.12B 136B | P/E 2026 * |
-20.9x | P/E 2027 * | -17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 494M 669M 578M 543M 929M 64.08B 943M 6.37B 2.5B 32.05B 2.51B 2.46B 107B | EV / Sales 2026 * |
1,521x | EV / Sales 2027 * | 604x |
| Free-Float |
69.35% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Silence Therapeutics plc
| 1 day | -8.18% | ||
| 1 week | +20.22% | ||
| Current month | +266.67% | ||
| 1 month | +266.67% | ||
| 3 months | +278.66% | ||
| 6 months | +243.75% | ||
| Current year | +175.00% |
| 1 week | 5.5 |  | 5.5 |
| 1 month | 3.96 | | 5.99 |
| Current year | 1.06 | | 5.99 |
| 1 year | 1.06 | | 5.99 |
| 3 years | 0.5 | | 14.75 |
| 5 years | 0.5 | | 46.5 |
| 10 years | 0.5 | | 46.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 01/12/2025 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 01/02/2022 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 21/06/2018 |
Iain Ross
CHM | Chairman | 72 | 01/01/2004 |
Tim McInerney
BRD | Director/Board Member | 65 | 05/05/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.18% | +20.22% | - | - | 864M | |
| -0.11% | -1.67% | +1.80% | +19.90% | 48.84B | |
| +1.89% | +5.08% | +492.59% | +629.24% | 45.44B | |
| +1.83% | +2.75% | +15.61% | +91.22% | 41.22B | |
| -0.50% | -1.56% | +24.67% | +12.17% | 39.71B | |
| -2.74% | -7.13% | +18.72% | +49.04% | 32.6B | |
| -1.14% | -2.51% | +27.52% | +136.42% | 16.67B | |
| +0.59% | -2.25% | - | - | 16.25B | |
| -0.49% | -0.34% | +3.45% | +29.14% | 14.08B | |
| -2.60% | -1.00% | +77.85% | +40.37% | 13.68B | |
| Average | -1.14% | -0.89% | +82.78% | +125.94% | 29.83B | |
| Weighted average by Cap. | -0.05% | -0.41% | +104.17% | +153.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 325K 440K 380K 357K 611K 42.13M 620K 4.19M 1.64M 21.07M 1.65M 1.61M 70.18M | 751K 1.02M 878K 826K 1.41M 97.37M 1.43M 9.69M 3.8M 48.7M 3.82M 3.73M 162M |
| Net income | -41.45M -56.12M -48.47M -45.61M -77.96M -5.38B -79.1M -535M -210M -2.69B -211M -206M -8.96B | -66.28M -89.74M -77.51M -72.93M -125M -8.6B -126M -855M -335M -4.3B -337M -330M -14.32B |
| Net Debt | -133M -180M -156M -146M -250M -17.27B -254M -1.72B -673M -8.64B -677M -662M -28.76B | -174M -236M -204M -191M -327M -22.58B -332M -2.25B -880M -11.29B -885M -866M -37.61B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/08/26 | $5.500 | -8.18% | 550 |
| 12/08/26 | $5.990 | +30.93% | 1,021 |
| 11/08/26 | $4.575 | +1.67% | 350 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
- SLNCF Stock
Select your edition
All financial news and data tailored to specific country editions
